Abstract
Human medicines European public assessment report (EPAR): Darzalex, daratumumab, Multiple Myeloma, Date of authorisation: 28/04/2017, Revision: 9, Status: Authorised
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have